Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...
Destiny 2 Episode Heresy is buffing Scout Rifles in PvE content, allowing this long-forgotten weapon to shine at last.
Zacks.com on MSN2h
FDA Expands Label of AZN's Enhertu for New Breast Cancer IndicationAstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application ...
Pep Guardiola says it is a "dream" for Manchester City to have their UEFA Champions League fate in their own hands ahead of the "challenge" of Club Brugge.
The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.
Queen Destiny Taylor, a 25-year-old mother of two, has been missing since August, and her family fears she has fallen victim ...
The Destiny 2 Heresy Act 1 developer livestream is scheduled to begin at 10:00 a.m. PT / 1:00 p.m. ET on January 28, 2025. We ...
Destiny 2 players are once again begging Bungie to revert a nerf from last year that has ruined a weapon for many.
The Last Wish loot table is one of the best in Destiny 2, as it features a range of meta raid weapons and armor you need.
The FDA has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for HR-positive, HER2-low or HER2-ultralow metastatic breast cancer.
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback